alt

About Genlight MedTech

Genlight Medical

Introduction

Genlight MedTech was founded in 2020 in Hangzhou, is a sci-tech platform enterprise focused on industrializing cutting-edge technologies in the fields of neuroscience and neurosurgery. The company has established advanced technology platforms in brain-computer interface, medical lasers, and brain-computer chip, providing innovative instrumental solutions for neurological disorders. Developed products include a magnetic resonance-guided laser ablation system, an implantable closed-loop responsive neurostimulation system for epilepsy and Parkinson's disease, as well as an SEEG electrode, 2 of these products have received breakthrough designation from NMPA. Genlight MedTech believes in innovation and cares for the welfare of patients. With a global scope and integration between industry and research, we always strive to be a reliable leader in providing solutions in the neuromedical domain.

Contact Genlight MedTech

Patent

108+
Invention Patent
89+
Utility Patent
24+
Design Patent
30+
Overseas Patent

Milestones

  • 2024

    • Epilcure™ has been selected into the "Top Ten Innovative Cases of the Brain-Computer Interface Industry in 2024".

    • Research and Development Center of High-tech Enterprises in Zhejiang Province

    • SMEs in Zhejiang Province featuring specialization, refinement, distinctiveness and innovation

    • The Most Investable Enterprise in Zhejiang Province

    • Council Member Unit of the National Biomedical Enterprise Platform

  • 2023

    • Hangzhou Future Unicorn

    • China Future Unicorn

    • Hangzhou Enterprise High-tech R&D Center

    • MTl Asia Pacific 2023 Accelerator Program

    • Series B+ funding(Tens of millions of RMB)

    • Top 100 Emerging Chinese Medical device Enterprises

    • LaserROTM received breakthrough device designation from NMPA

  • 2022

    • Established a Graduate Joint Training Center with Zhejiang University of Technology

    • Become a board member of Yuhang District Biomedical Industry Association

    • Top 100 Innovative Medical Device Companies in China

    • First Enrollment of Clinical Trial ofLaserROTM in China

    • LaserRO™ won first prize in the 5th China Medical Device Innovation and Entrepreneurship Competition

    • Epilcure™ received breakthrough device designation from NMPA

    • Most Investment-Worthy Innovative Enterprise in Zhejiang

  • 2021

    • Pre-Series A funding(Tens of millions of RMB)

    • Acquisition of Hangzhou Nuowei Medical

    • Series A funding(Tens of millions of RMB)

    • The first implantation of Epilcure™

    • Launch of Epilcure™ Multi-Center RCT

    • Epilcure™ won first prize in the 4th China Medical Device Innovation and Entrepreneurship Competition

    • Series B funding(Hundreds of millions of RMB)

    • Venture 50 winner

  • 2020

    • Genlight MedTech was established in Zhejiang Overseas High-Level Talents Innovation Park

    • Reviewed by Hangzhou Future Sci-Tech City Management Committee as Priority Recommended Overseas High-Level Talent Project

    • Angel funding(3.5 million RMB)

    • Second Prize in the Hangzhou Overseas High-Level Talent Innovation and Entrepreneurship Competition

    • The first-generation prototype of LaserRO™

Media Reports

Hunan Satellite TV —— How to Treat Epileptic Patients

brain-computer interface is a reality